Search bioRxivSearch

bioRxiv · 10.1101/354977

Antioxidant Gene Expression in Vocal Hindbrain of a Teleost Fish

Abstract

Plainfin midshipman fish (Porichthys notatus) have a remarkable capacity to generate long duration advertisement calls known as hums, each of which may last for close to two hours and be repeated throughout a night of courtship activity during the breeding season. The midshipmans striking sound production capabilities provide a unique opportunity to investigate the mechanisms that motor neurons require for withstanding high-endurance activity. The temporal properties of midshipman vocal behaviors are largely controlled by a hindbrain central pattern generator that includes vocal motor neurons (VMN) that directly determine the activity pattern of target sonic muscles and, in turn, a sounds pulse repetition rate, duration and pattern of amplitude modulation. Of the two adult midshipman male reproductive phenotypes -- types I and II-- only type I males acoustically court females with hums from nests that they build and guard, while type II males do not produce courtship hums but instead sneak or satellite spawn to steal fertilizations from type I males. A prior study using next generation RNA sequencing showed increased expression of a number of cellular respiration and antioxidant genes in the VMN of type I males during the breeding season, suggesting they help to combat potentially high levels of oxidative stress linked to this extreme behavior. This led to the question of whether the expression of these genes in the VMN would vary between actively humming versus non-humming states as well as between male morphs. Here, we tested the hypothesis that to combat oxidative stress, the VMN of reproductively active type I males would exhibit higher mRNA transcript levels for two superoxide dismutases (sod1, sod2) compared to the VMN of type II males and females that do not hum and in general both of which have a more limited vocal repertoire than type I males. The results showed no significant difference in sod1 transcript expression across reproductive morphs in the VMN and the surrounding hindbrain, and no difference of sod2 across the two male morphs and females in the SH. However, we observed a surprising, significantly lower expression of sod2 transcripts in the VMN of type I males as compared to type II males. We also found no significant difference in sod1 and sod2 expression between actively humming and non-humming type I males in both the VMN and surrounding hindbrain. These findings overall lead us to conclude that increased transcription of sod1 and sod2 is not necessary for combatting oxidative stress from the demands of the midshipman high-endurance vocalizations, but warrant future studies to assess protein levels, enzyme activity levels, as well as the expression of other antioxidant genes. These results also eliminate one of the proposed mechanisms that male midshipman use to combat potentially high levels of oxidative stress incurred by motor neurons driving long duration vocalization and provide more insight into how motor neurons are adapted to the performance of extreme behaviors.

Explore related subjects

Keep this discovery

BibTeXRIS

Liao, C., Feng, N. Y., Bass, A. H.. 2018-06-26. Antioxidant Gene Expression in Vocal Hindbrain of a Teleost Fish. https://doi.org/10.1101/354977

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience